Seth Klarman · Q4 2019
Baupost Group
Portfolio at the end of Q4 2019, from the 13F filed February 13, 2020. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Liberty Global LBTYK · history | 12.6% | Q3 2018 | Add 19% |
| Fox Corporation FOXA · history | 11.2% | Q1 2019 | No change |
| Viasat VSAT · history | 11.1% | Q2 2013 or earlier | No change |
| eBay EBAY · history | 8.0% | Q4 2018 | Add 20% |
| Paramount PARA · history | 7.9% | Q4 2019 | Buy |
| Cheniere Energy LNG · history | 6.8% | Q1 2014 | No change |
| Tesla TSLA.CV · convertible notes · history | 4.7% | Q1 2018 | No change |
| Qorvo QRVO · history | 3.5% | Q1 2017 | Reduce 52% |
| Bristol-Myers Squibb BMY · history | 2.8% | Q1 2019 | Reduce 60% |
| Theravance Biopharma TBPH · history | 2.7% | Q2 2014 | No change |
| DigitalBridge CLNY · history | 2.6% | Q2 2018 | No change |
| Nexstar Media Group NXST · history | 2.6% | Q4 2018 | No change |
| Univar Solutions UNVR · history | 2.5% | Q3 2018 | No change |
| McKesson MCK · history | 2.4% | Q3 2017 | Add 22% |
| Fox Corporation FOX · history | 2.3% | Q1 2019 | No change |
| HP HPQ · history | 2.3% | Q4 2019 | Buy |
| PG&E PCG · history | 2.3% | Q1 2018 | Reduce 23% |
| Liberty Global LBTYA · history | 1.9% | Q3 2018 | No change |
| Translate Bio TBIO · history | 1.6% | Q2 2018 | No change |
| Atara Biotherapeutics ATRA · history | 1.5% | Q4 2014 | No change |
| Akebia Therapeutics AKBA · history | 1.4% | Q4 2018 | Reduce 20% |
| Synchrony SYF · history | 1.2% | Q3 2016 | Reduce 40% |
| Cencora COR · history | 1.1% | Q3 2017 | No change |
| Veritiv VRTV · history | 0.8% | Q3 2014 | No change |
| Vista Energy VIST · history | 0.5% | Q3 2019 | No change |
| Nuance Communications NUAN · history | 0.5% | Q3 2019 | Reduce 72% |
| Cars.com CARS · history | 0.4% | Q3 2019 | Reduce 10% |
| Trilogy Metals TMQ · history | 0.3% | Q2 2013 or earlier | No change |
| Theravance Biopharma TBPH.CV · convertible notes · history | 0.3% | Q4 2016 | No change |
| Caesars Entertainment ERI · history | 0.3% | Q4 2019 | Buy |
| McDermott International MDR · history | 0.0% | Q4 2019 | Buy |
| 31 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2019, adjusted for stock splits.
Sector weighting
| Media & telecom | 49.6% | |
|---|---|---|
| Health care | 13.8% | |
| Consumer discretionary | 12.9% | |
| Energy | 7.4% | |
| Technology | 6.6% | |
| Financials & real estate | 3.8% | |
| Industrials | 3.3% | |
| Utilities | 2.3% | |
| Materials | 0.3% |
What changed from Q3 2019
- Buy Paramount PARA 7.9% of the 13F
- Buy HP HPQ 2.3% of the 13F
- Buy Caesars Entertainment ERI 0.3% of the 13F
- Buy McDermott International MDR 0.0% of the 13F
- Add 19% Liberty Global LBTYK 11.8% → 12.6%
- Add 20% eBay EBAY 7.3% → 8.0%
- Add 22% McKesson MCK 2.0% → 2.4%
- Reduce 52% Qorvo QRVO 4.8% → 3.5%
- Reduce 60% Bristol-Myers Squibb BMY 5.7% → 2.8%
- Reduce 23% PG&E PCG 2.8% → 2.3%
- Reduce 20% Akebia Therapeutics AKBA 1.1% → 1.4%
- Reduce 40% Synchrony SYF 1.9% → 1.2%
- Reduce 72% Nuance Communications NUAN 1.5% → 0.5%
- Reduce 10% Cars.com CARS 0.3% → 0.4%
- Sell CBS CBS was 5.5%
- Sell Takeda Pharmaceutical TAK was 1.8%
- Sell Antero Resources AR was 0.7%
- Sell Gossamer Bio GOSS was 0.2%
- Sell Paratek Pharmaceuticals PRTK was 0.1%